Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atina Ativos Naturais is a Brazilian biotechnology company dedicated to developing and producing active ingredients derived from Brazilian biodiversity. The company is recognized as a global leader in the production of natural alpha-bisabolol, an anti-inflammatory and soothing agent extracted from the Candeia tree. Atina's operations are characterized by a commitment to sustainability, evidenced by its Forest Stewardship Council (FSC) certification and ethical sourcing practices. Their product portfolio serves the pharmaceutical, dermo-cosmetic, and personal care industries, providing high-purity natural alternatives to synthetic compounds. Headquartered in Minas Gerais, the company integrates research, sustainable harvesting, and advanced extraction technologies to supply international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atina Ativos Naturais.